Melola Discovery

← Melola Discovery

Jurnal Tanpa peringkat SINTA

AKTIVITAS SITOTOKSIK PROPRANOLOL TERHADAP SEL KANKER PAYUDARA MCF7 IN VITRO

Jambi Medical Journal : Jurnal Kedokteran dan Kesehatan · Vol. 6 No. 2 (2018) · hlm. 171–175

DOI
10.22437/jmj.v6i2.5970
ISSN
2580-6874, 2339-269X
Terbit
2018-11-01
Penerbit
FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS JAMBI
Bahasa
en

Abstrak

Background: Propranolol is a nonselective beta-blocker drug which is commonly used as an antihypertensive. In vitro studies showed that propranolol has anti-proliferative, anti-migratory and cytotoxic effects on cancer cells of lung, colon, breast, nasopharynx, ovarian pancreas and gastric. Therefore, this study is conducted to assess whether propranolol has cytotoxic activity of MCF7 breast cancer cells. Research objectives: This study aimed to assess the effects of propranolol on the cytotoxic activity of MCF7 breast cancer cells. Research methods: This quasi-experimental research using post-test with a non-equivalent control group design. Cytotoxicity test using MTT assay was performed to determine the IC50 propranolol against MCF7 cells. Results: Propranolol showed cytotoxic activity against MCF7 breast cancer cells with IC50 value of 227.91 ± 14.74 µM (67,41±4,35 µg/mL). Conclusion: Propranolol has cytotoxic activity against MCF7 breast cancer cells. Keywords: propranolol, cytotoxic, MCF7

Sumber metadata: OAI-PMH (metadata jurnal) https://online-journal.unja.ac.id/index.php/kedokteran/oai, pertama di-harvest 6 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">AKTIVITAS SITOTOKSIK PROPRANOLOL TERHADAP SEL KANKER PAYUDARA MCF7 IN VITRO</dc:title>
	<dc:description xml:lang="en">Background: Propranolol is a nonselective beta-blocker drug which is commonly used as an antihypertensive. In vitro studies showed that propranolol has anti-proliferative, anti-migratory and cytotoxic effects on cancer cells of lung, colon, breast, nasopharynx, ovarian pancreas and gastric. Therefore, this study is conducted to assess whether propranolol has cytotoxic activity of MCF7 breast cancer cells.
Research objectives: This study aimed to assess the effects of propranolol on the cytotoxic activity of MCF7 breast cancer cells.
Research methods: This quasi-experimental research using post-test with a non-equivalent control group design. Cytotoxicity test using MTT assay was performed to determine the IC50 propranolol against MCF7 cells.
Results: Propranolol showed cytotoxic activity against MCF7 breast cancer cells with IC50 value of 227.91 ± 14.74 µM (67,41±4,35 µg/mL). 
Conclusion: Propranolol has cytotoxic activity against MCF7 breast cancer cells.
&amp;nbsp;Keywords: propranolol, cytotoxic, MCF7</dc:description>
	<dc:publisher xml:lang="en">FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS JAMBI</dc:publisher>
	<dc:date>2018-11-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://online-journal.unja.ac.id/kedokteran/article/view/5970</dc:identifier>
	<dc:identifier>10.22437/jmj.v6i2.5970</dc:identifier>
	<dc:source xml:lang="en">Jambi Medical Journal : Jurnal Kedokteran dan Kesehatan; Vol. 6 No. 2 (2018): JAMBI MEDICAL JOURNAL Jurnal Kedokteran Dan Kesehatan; 171-175</dc:source>
	<dc:source>2580-6874</dc:source>
	<dc:source>2339-269X</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://online-journal.unja.ac.id/kedokteran/article/view/5970/3891</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2018 JAMBI MEDICAL JOURNAL "Jurnal Kedokteran dan Kesehatan"</dc:rights>
</oai_dc:dc>